182199
Participation and practices in non-prescription syringes sales (NPSS) by pharmacies in Los Angeles and San Francisco, 2007
Tuesday, October 28, 2008: 2:54 PM
Richard S. Garfein, PhD, MPH
,
Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA
Erin Cooper
,
Urban Community Research Center, California State University Dominguez Hills, Carson, CA
Thomas Stopka, MHS
,
Epidemiologic Studies Section, California Department of Health Services, Office of AIDS, Sacramento, CA
Elise D. Riley, PhD
,
Department of Medicine, University of California, San Francisco, San Francisco, CA
Ricky N. Bluthenthal, PhD
,
Department of Preventive Medicine Institute for Prevention Research Keck School of Medicine, University of Southern California, Alhambra, CA
Objective: To describe participation by pharmacists in non-prescription syringe sales (NPSS) to injection drug users (IDUs) and to determine pharmacy-specific factors associated with NPSS in Los Angeles (LA) and San Francisco (SF). Methods: Telephone and in-person interviews with a pharmacy staff person in zip-codes with high proportions of IDUs in publically-funded substance abuse treatment in LA and SF were conducted. A total of 238 pharmacy surveys were completed in 2007 (n=67 in SF; n=171 in LA) with a response rate of 72%. Survey items covered whether pharmacies had registered with the county, engage in NPSS, required other information to sale, attitudes regarding HIV and HCV prevention for IDUs, and if they refused to sell syringes under certain conditions. Descriptive, bivariate and multivariate statistics were used to examine these data. Results: Overall, 42% of pharmacies reported NPSS (81% in SF; 28% in LA) although only 33% had registered with their county government as required by law (76% in SF; 17% in LA). In multivariate analyses, NPSS was associated with SF city, some attitude items, and being a chain pharmacy. Many pharmacies required proof of medical condition (55%) for NPSS (31% in SF; 80% in LA). Many pharmacies reported refusing NPSS if the customer was a known or suspected IDU (74% in LA & 33% in SF). Discussion: More research is needed to understand factors pharmacy decision-making regarding NPSS. Additional educational and advocacy efforts are required to increase pharmacy participation and lower obstacles to NPSS among pharmacies that do sell.
Learning Objectives: Describe the level of pharmacy participation in non-prescription syringe sales in Los Agneles and San Francisco, California.
Identify factors associated with pharmacy participation in NPSS.
Describe the on-going barriers to NPSS by pharmacies in these two locales.
Keywords: HIV/AIDS, Policy/Policy Development
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I helped design the study, oversaw data collection, participated in data analysis, write-up and final approval of abstract text.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|